Table 2

Sample characteristics and comparisons of self-efficacy and anticoagulation adherence among different characteristics of patients with atrial fibrillation (n=151)

VariablesNSelf-efficacyAdherence
M±SDF/tP valueM±SDF/tP value
Gender−1.560.1211.500.135
 Female5631.9±6.89.1±2.1
 Male9533.5±5.68.7±1.7
Educational level0.170.9150.370.779
 Primary school and below5132.9±6.28.8±1.9
 Middle school2133.5±7.18.8±2.2
 High school3333.1±5.88.6±1.9
 College and above4632.4±5.79.0±1.7
Marital status1.180.238−0.520.604
 Married12532.6±5.98.9±1.9
 Single, divorced or widowed2634.2±6.98.7±2.0
Employment status0.540.5840.730.482
 Full time, part-time2932.9±6.59.2±2.0
 Retired10733.1±5.78.7±1.8
 Unemployed1531.3±7.68.7±2.0
CHA2DS2-VASC 0.180.86−0.820.416
 Low-middle risk933.2±6.18.3±1.6
 High risk14232.9±6.18.9±1.9
HAS-BLED0.920.360−0.860.392
Low risk6033.4±6.08.7±1.8
High risk9132.5±6.148.9±1.9
Anticoagulants1.370.172−0.990.324
 Warfarin5333.8±4.98.6±1.6
 NOACs9832.4±6.68.9±2.0
Dosing frequency0.080.9220.450.641
 Once a day13532.9±6.08.8±1.9
 Twice a day1133.5±6.99.3±1.6
 Once every 2 days532.2±7.18.4±1.4
Number of adverse reactions1.180.320–2.150.096
 None7733.4±5.78.7±1.8
 One5133.0±6.38.8±1.7
 Two1430.9±6.78.7±1.9
 Three and more930.4±7.010.3±2.5
  • F, the value of one-way analysis of variables; NOACs, novel oral anticoagulants; t, the value of dependent t-test.